Cytosponge-TFF3 Testing can Detect Precancerous Mucosal Changes of the Stomach.

Autor:	Hadjinicolaou AV; MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom; Department of Digestive Diseases, Addenbrooke's Hospital, Cambridge, United Kingdom., Azizi AA; Department of Clinical Pharmacology and Therapeutics, Addenbrooke's Hospital, Cambridge, United Kingdom., O'Donovan M; Department of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom., Debiram I; MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom., Fitzgerald RC; MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom., Di Pietro M; MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom; Department of Digestive Diseases, Addenbrooke's Hospital, Cambridge, United Kingdom. Electronic address: md460@cam.ac.uk.
Jazyk:	angličtina
Zdroj:	Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2022 Jun; Vol. 20 (6), pp. 1411-1412. Date of Electronic Publication: 2021 Aug 03.
DOI:	10.1016/j.cgh.2021.07.047
Abstrakt:	Gastric intestinal metaplasia (GIM) and gastric atrophy (GA) are associated with increased risk of gastric cancer and are indications for endoscopic surveillance when affecting the proximal stomach. 1 Endoscopic screening is not cost-effective in areas with low-moderate incidence of gastric cancer 2 ; noninvasive methods to detect GIM/GA are currently lacking. 3 . (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu